Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

James Schneider

Physician Assistant Fort Mill, SC Physician Assistant

NPI 1750939674 CMS profile 11013835

601 S Sutton Rd Ste 101, Fort Mill, SC 29715

Open in the dashboard

General payments

$3,962

27 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, James Schneider of Fort Mill, SC is reported in the CMS Open Payments database as having received $3,962 across 27 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $17 1
2023 General $1,270 15
2022 General $2,651 10
2021 General $24 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Schneider
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to James Schneider were reported at $17. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year James Schneider Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $24 $132 $37–$438 $132
2022 $2,651 $155 $48–$522 $149
2023 $1,270 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $17 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Peerless Surgical Inc. $3,265 11 payments
  2. Arthrex, Inc. $438 7 payments
  3. Ethicon US, LLC $97 2 payments
  4. AbbVie, Inc. $64 3 payments
  5. Bioventus LLC $43 2 payments
  6. DePuy Synthes Sales Inc. $37 1 payment
  7. Naviswiss, Inc. $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Education $2,400 2 payments
  2. Food and Beverage $835 21 payments
  3. Travel and Lodging $727 4 payments
Products named General payments · program years 2021–2025
  1. STRATAFIX $97 2 payments
  2. SURGIFLO Hemostatic Matrix $74 1 payment
  3. UBRELVY $64 3 payments
  4. VA-LCP $37 1 payment
  5. Fibulink $37 1 payment
  6. Exogen Ultrasound Bone Healing System $24 1 payment
  7. DERMABOND PRINEO $24 1 payment
  8. Durolane $20 1 payment
  9. Naviswiss Knee Navigation $17 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

398

Median for Physician Assistant: 241

Drug cost

$2,319

Median for Physician Assistant: $4,110

Branded share of claims

39.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 102 $776
Diclofenac Sodium Generic 44 $427
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 54 $373
Methylprednisolone Generic 39 $297
Tramadol Hcl Generic 49 $161
Gabapentin Generic 18 $82
Cephalexin Generic 19 $78
Meloxicam Generic 17 $46
Clindamycin Hcl Generic 15 $43
Amoxicillin Generic 41 $36

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 54 billing codes

Paid by Medicare

$77,473

Of which drugs: $10,365

Medicare patients

363

Average age 75

Services billed

4,872

243 women, 120 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 31%
Diabetes 23%
Depression 23%
Osteoporosis 22%
Chronic kidney disease 20%
Atrial fibrillation 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg J7318 Office 17 1,620 $8,276
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 104 1,748 $1,328

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

27 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record